At the Oct 13 close, 2 rose and 2 fell, with a median move of 0.0%. Of the 5 stocks with a prior-session comparison, 2 improved relative strength and 3 improved momentum.
Compare 5 tracked South Korean companies in medical devices & diagnostics: what they do, where they fit in the industry, and their local share prices.
Diagnostic devices, medical imaging, and digital health
Prices are in South Korean won (KRW). Stock codes identify local KOSPI or KOSDAQ listings, not US ADRs. These are closing-price observations, not a real-time feed.
Highest composite score in this tracked group: DENTIUM. This is a multi-factor score, not relative strength alone.
| Company / listing | Close (KRW) | Change | Market cap (KRW) | Composite score |
|---|---|---|---|---|
| DENTIUMKOSPI · 145720 | 39,3002026-10-13 | +1.81% | 338.9B | 62.82026-10-13 |
| Lunit Inc.KOSDAQ · 328130 | 11,3502026-10-13 | +3.28% | 845.1B | 58.32026-10-13 |
| SEEGENE, INC.KOSDAQ · 096530 | 36,7002026-10-13 | -2.13% | 1.7T | 48.12026-10-13 |
| 3billion Inc.KOSDAQ · 394800 | 5,5802026-10-13 | 0.00% | 177.6B | 45.42026-10-13 |
| InBody Co., Ltd.KOSDAQ · 041830 | 50,1002026-10-13 | -1.96% | 675.4B | 36.42026-10-13 |
The 0–100 composite combines relative strength (30%), momentum (20%), volume (15%), ETF weight (15%), node correlation (5%), new inclusion (5%) and short-squeeze positioning (10%). It is not a return forecast or a pure relative-strength ranking. A dash means data is unavailable, not zero.
Business roles are separate from the site's screening rules. ETF inclusion or pension-fund ownership does not establish a company's product mix. Source-backed notes below explain our classification; they do not quantify revenue exposure or recommend a trade.
Dentium makes dental implants and related equipment. Overseas markets, China in particular, account for a large share of sales, leaving it sensitive to local demand and regulation.
Company source: DART company overview — DENTIUM · Reviewed 2026-09-18
Lunit builds artificial-intelligence software that reads chest X-rays and mammograms. It sells diagnostic software rather than hardware.
Company source: DART company overview — Lunit Inc. · Reviewed 2026-09-18
Seegene supplies molecular diagnostic reagents and instruments. Its revenue base shifted substantially as pandemic-era demand normalised.
Company source: DART company overview — SEEGENE, INC. · Reviewed 2026-09-18
3billion provides genome analysis for diagnosing rare genetic disorders. Its business is the analysis and interpretation service, not the sequencing hardware.
Company source: DART company overview — 3billion Inc. · Reviewed 2026-09-18
InBody makes body-composition analysers for hospitals and fitness facilities. It sells measurement devices, not pharmaceuticals.
Company source: DART company overview — InBody Co., Ltd. · Reviewed 2026-09-18